Literature DB >> 22369502

Marburg virus glycoprotein GP2: pH-dependent stability of the ectodomain α-helical bundle.

Joseph S Harrison1, Jayne F Koellhoffer, Kartik Chandran, Jonathan R Lai.   

Abstract

Marburg virus (MARV) and Ebola virus (EBOV) constitute the family Filoviridae of enveloped viruses (filoviruses) that cause severe hemorrhagic fever. Infection by MARV requires fusion between the host cell and viral membranes, a process that is mediated by the two subunits of the envelope glycoprotein, GP1 (surface subunit) and GP2 (transmembrane subunit). Upon viral attachment and uptake, it is believed that the MARV viral fusion machinery is triggered by host factors and environmental conditions found in the endosome. Next, conformational rearrangements in the GP2 ectodomain result in the formation of a highly stable six-helix bundle; this refolding event provides the energetic driving force for membrane fusion. Both GP1 and GP2 from EBOV have been extensively studied, but there is little information available for the MARV glycoproteins. Here we have expressed two variants of the MARV GP2 ectodomain in Escherichia coli and analyzed their biophysical properties. Circular dichroism indicates that the MARV GP2 ectodomain adopts an α-helical conformation, and one variant sediments as a trimer by equilibrium analytical ultracentrifugation. Denaturation studies indicate the α-helical structure is highly stable at pH 5.3 (unfolding energy, ΔG(unf,H(2)O), of 33.4 ± 2.5 kcal/mol and melting temperature, T(m), of 75.3 ± 2.1 °C for one variant). Furthermore, we found the α-helical stability to be strongly dependent on pH, with higher stability under lower-pH conditions (T(m) values ranging from ~92 °C at pH 4.0 to ~38 °C at pH 8.0). Mutational analysis suggests two glutamic acid residues (E579 and E580) are partially responsible for this pH-dependent behavior. On the basis of these results, we hypothesize that the pH-dependent folding stability of the MARV GP2 ectodomain provides a mechanism for controlling conformational preferences such that the six-helix bundle "postfusion" state is preferred under conditions of appropriately matured endosomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22369502      PMCID: PMC3314129          DOI: 10.1021/bi3000353

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  50 in total

1.  X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation.

Authors:  Sébastien Igonet; Marie-Christine Vaney; Clemens Vonrhein; Clemens Vonhrein; Gérard Bricogne; Enrico A Stura; Hans Hengartner; Bruno Eschli; Félix A Rey
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

2.  Discovery of biphasic thermal unfolding of ompc with implications for surface loop stability.

Authors:  Neil Keegan; Helen Ridley; Jeremy H Lakey
Journal:  Biochemistry       Date:  2010-10-20       Impact factor: 3.162

3.  Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G.

Authors:  Stéphane Roche; Félix A Rey; Yves Gaudin; Stéphane Bressanelli
Journal:  Science       Date:  2007-02-09       Impact factor: 47.728

4.  Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain.

Authors:  W Weissenhorn; A Carfí; K H Lee; J J Skehel; D C Wiley
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

5.  Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change.

Authors:  Matthew Brecher; Kathryn L Schornberg; Sue E Delos; Marnie L Fusco; Erica Ollmann Saphire; Judith M White
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

6.  Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

Authors:  Kartik Chandran; Nancy J Sullivan; Ute Felbor; Sean P Whelan; James M Cunningham
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

7.  Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry.

Authors:  Sue E Delos; Bonnie La; Allissia Gilmartin; Judith M White
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

8.  Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution.

Authors:  V N Malashkevich; B J Schneider; M L McNally; M A Milhollen; J X Pang; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  Mechanism of specificity in the Fos-Jun oncoprotein heterodimer.

Authors:  E K O'Shea; R Rutkowski; P S Kim
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

Review 10.  Dealing with low pH: entry and exit of alphaviruses and flaviviruses.

Authors:  Claudia Sánchez-San Martín; Catherine Y Liu; Margaret Kielian
Journal:  Trends Microbiol       Date:  2009-09-30       Impact factor: 17.079

View more
  22 in total

1.  Structural and Functional Studies on the Marburg Virus GP2 Fusion Loop.

Authors:  Nina Liu; Yisong Tao; Michael D Brenowitz; Mark E Girvin; Jonathan R Lai
Journal:  J Infect Dis       Date:  2015-03-18       Impact factor: 5.226

2.  Membrane requirement for folding of the herpes simplex virus 1 gB cytodomain suggests a unique mechanism of fusion regulation.

Authors:  Jessica L Silverman; Neil G Greene; David S King; Ekaterina E Heldwein
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  A switch from parallel to antiparallel strand orientation in a coiled-coil X-ray structure via two core hydrophobic mutations.

Authors:  Vladimir N Malashkevich; Chelsea D Higgins; Steven C Almo; Jonathan R Lai
Journal:  Biopolymers       Date:  2015-05       Impact factor: 2.505

4.  Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity.

Authors:  Jinwoo Lee; David A Nyenhuis; Elizabeth A Nelson; David S Cafiso; Judith M White; Lukas K Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

5.  Crystal structure of the Marburg virus GP2 core domain in its postfusion conformation.

Authors:  Jayne F Koellhoffer; Vladimir N Malashkevich; Joseph S Harrison; Rafael Toro; Rahul C Bhosle; Kartik Chandran; Steven C Almo; Jonathan R Lai
Journal:  Biochemistry       Date:  2012-09-19       Impact factor: 3.162

Review 6.  Role of electrostatic repulsion in controlling pH-dependent conformational changes of viral fusion proteins.

Authors:  Joseph S Harrison; Chelsea D Higgins; Matthew J O'Meara; Jayne F Koellhoffer; Brian A Kuhlman; Jonathan R Lai
Journal:  Structure       Date:  2013-07-02       Impact factor: 5.006

7.  Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.

Authors:  Rebecca M Mingo; James A Simmons; Charles J Shoemaker; Elizabeth A Nelson; Kathryn L Schornberg; Ryan S D'Souza; James E Casanova; Judith M White
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

8.  Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibody.

Authors:  Daniel Hofmann; Samantha E Zak; Elisabeth K Nyakatura; Eva Mittler; Russell R Bakken; Kartik Chandran; John M Dye; Jonathan R Lai
Journal:  Immunol Lett       Date:  2017-09-08       Impact factor: 3.685

9.  Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein.

Authors:  Jayne F Koellhoffer; Gang Chen; Rohini G Sandesara; Shridhar Bale; Erica Ollmann Saphire; Kartik Chandran; Sachdev S Sidhu; Jonathan R Lai
Journal:  Chembiochem       Date:  2012-10-30       Impact factor: 3.164

10.  Crystal structures of beta- and gammaretrovirus fusion proteins reveal a role for electrostatic stapling in viral entry.

Authors:  Halil Aydin; Jonathan D Cook; Jeffrey E Lee
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.